“Just drink chamomile tea” is common advice for people curious about apigenin, and it’s not wrong exactly — but it understates how large the gap is between a cup of tea and a standardized 50 mg capsule. This article works through what’s actually in a cup, based on human pharmacokinetic and HPLC data rather than rough estimates, so you can decide whether tea or a supplement fits what you’re trying to accomplish.
Key Takeaways
- Most of the apigenin in chamomile tea exists as apigenin-7-O-glucoside, a bound glycoside form, not free apigenin.
- A human pharmacokinetic study found a 450 mL serving of chamomile tea delivered relatively small amounts of the flavone, with urinary recovery of its metabolites equivalent to roughly a third of the ingested glycoside dose.
- Commonly cited estimates put free apigenin content around 0.8-3 mg per cup, well below the 25-50 mg found in a typical supplement capsule.
- Tea is a reasonable, low-cost way to get modest, regular exposure with a long safety track record; it is not a substitute for a standardized dose if you’re targeting a specific effect size studied at 25-50 mg.
Free Apigenin vs Bound Glycosides
Chamomile flowers contain apigenin mostly in glycoside-bound forms — chiefly apigenin-7-O-glucoside — rather than as the free aglycone that supplement capsules typically contain. This matters because the body has to cleave that glycoside bond (largely via gut bacteria and intestinal enzymes) before the apigenin portion becomes bioavailable in its active form, adding a metabolic step that a standardized capsule skips.
What a Human Pharmacokinetic Study Found
A controlled human study tracked absorption after a 450 mL serving of chamomile tea and found it delivered comparatively small amounts of the flavone principally as apigenin-7-O-glucoside, with smaller amounts of free apigenin[1]. Urinary excretion of apigenin metabolites over 0-24 hours after chamomile tea intake was equivalent to roughly 34% of the ingested glycoside amount — a meaningfully higher recovery rate than free apigenin taken alone, which the same study found was poorly absorbed on its own (urinary metabolite recovery equivalent to only about 0.5% of intake)[1]. In other words: the glycoside form in tea may actually be handled more efficiently by the body than free apigenin powder taken without any absorption-enhancing formulation — but the absolute starting amount in a cup of tea is still small.
Putting a Number On It
HPLC analysis of dried chamomile flower material has found apigenin derivatives making up roughly 0.3-0.4% of flower weight[2], but that’s raw flower composition, not a brewed cup — steeping time, water temperature, and how much flower material is actually in a tea bag all affect what ends up in your mug. Because of that variability, and because most of what’s measured is the bound glycoside rather than free apigenin, there isn’t a single peer-reviewed “mg per cup” figure that applies universally. Commonly cited estimates across supplement-industry and extraction sources put free apigenin content in the 0.8-3 mg per cup range — a full order of magnitude (or more) below the 25-50 mg typically used in standardized capsules.
What This Means Practically
If your goal is a mild, low-effort, long-history way to get some apigenin exposure as part of an evening routine, chamomile tea is a reasonable and inexpensive choice — its safety profile from centuries of use is genuinely a point in its favor. If your goal is to replicate the specific dose studies that use 25-50 mg apigenin, tea alone won’t get you there; you’d need an impractical number of cups, and even then the glycoside-vs-free-form difference complicates a direct comparison. A standardized capsule is the more predictable path if dose consistency matters to you.
References
- Borges G et al. Absorption, distribution, metabolism and excretion of apigenin and its glycosides in healthy male adults. Free Radical Biology and Medicine (2022). PMID 35452808
- Stanojevic LP et al. Phenolic Profile by HPLC-PDA-MS of Greek Chamomile Populations and Commercial Varieties and Their Antioxidant Activity. Antioxidants (2021). PMC8535277
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
